NeuroScience Associates Announces Expansion, Increases Capacity to Deliver High Quality Neurohistology Services

Share Article

NeuroScience Associates, Inc. (NSA), a global leader in mass-production neurohistology services, announces the opening of a new state-of-the-art facility. NSA projects that the new lab will quadruple its already high throughput capacity for brain and spinal cord histology used in medical and scientific research and development.

Our new laboratory will enable us to meet these needs and to keep R&D work on pace and below budget for our clients.

In an effort to meet the growing demands of pharmaceutical companies and research labs, NeuroScience Associates, Inc. (NSA), a global leader in mass-production neurohistology services, announces the opening of a new state-of-the-art facility. NSA projects that the new lab will quadruple its already high throughput capacity for brain and spinal cord histology used in medical and scientific research and development.

"Today's economic downturn is creating unfortunate bottlenecks and budget constraints for many pharmaceutical and research companies. Many of these organizations, in addition to our longstanding clients, are outsourcing all or part of their neurohistology needs to us," said Dr. Bob Switzer, founder and president of NSA. "Our new laboratory will enable us to meet these needs and to keep R&D work on pace and below budget for our clients."

By employing NSA's MultiBrain® technology, thousands of sections are stained simultaneously, eliminating the many variables, both human and environmental, that occur under conventional staining protocols. The company's experience in neurohistology has supported key research for solutions to many neurological ailments including Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Huntington's disease, stroke and neurotoxicity.

Based on recent calculations, MultiBrain® technology, the cornerstone of NSA's high quality and efficient neurohistologic processing, is up to eight times (8X) less expensive than other methods. Mass production neurohistology enables NSA to produce finished slides from the brains and/or spinal cords of hundreds of test animals in as little as three weeks per project. The larger, state-of-the-art laboratory and additional NSA team members will allow NSA to meet the ever-growing needs of clients.

As Dr. Andrew Steele from the California Institute of Technology states in a recent testimonial, "NSA was extremely helpful from my first interactions and throughout the project. NSA's commitment to customer satisfaction is unparalleled, and they are happy to help with the study design and will even find ways to help the customer get their pathology done in the most cost-effective manner. I have worked with several pathologists/clinical labs and am very impressed with the quality of tissue preservation and immunostaining using MultiBrain® technology. The work done by NSA is of the highest quality. I look forward to working with them in the future."

About NeuroScience Associates
A privately held company, founded in 1989, NSA specializes in a unique niche market as providers of high-throughput neurohistology services. Through NSA's proprietary MultiBrain® technology, researchers can significantly reduce their R&D cycle times. Rapid delivery, high quality and low cost of delivery are the results of this technology.

NeuroScience Associates' clients include academic and institutional researchers and all sizes of domestic and international pharmaceutical companies including 15 out of the top 20. For more information, contact Chris Massei @ 866-341-8191, 540-341-8191, or visit http://www.nsalabs.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

JODIE POZO OLANO
Visit website